TB Research

Tuberculosis: A Multi-Drug Risk Study in Al-Diwaniyah Governorate, Iraq

Hadi Jebur Suhail, Saad Mashkoor Waleed, Yasmeen Ali Hussien, Salim Fayez Kadhim

Systematic Reviews in Pharmacy · 2020-01

Abstract

Multidrug-resistant tuberculosis is the type whose presence is evidence of at least simultaneous rifampicin and Isonazide. Determining the in-adequacy of treatment is an important cause of this type of disorder and explains the technology that leads to its spread, and the study of many social-determinants that influence the threat of increased resistance. The main objectives are to perceive threat elements of MDR-TB amongst tuberculosis patients, in Diwaniyah province. The study found that to reduce the burden of drug resistance, MDR- TB control techniques in Diwaniyah should focus on several multi- sectoral measures, as well as on further addressing the Medical-Care and Social-Desires of TB-patient.

MeSH terms

  • Tuberculosis
  • Rifampicin
  • Medicine
  • Drug
  • Environmental health
  • Drug resistance
  • Multiple drug resistance
  • Health care
  • Intensive care medicine